Date: April 23, 2025
Location: Online
Type: Webinar
Description:
N/R
Event Materials and Resources
Title: Adopting USP Chapter <86>: Efficiently Transitioning to Recombinant Endotoxin Testing
Presenter: Alan Hoffmeister, Senior Global Scientific Portfolio Specialists, Microbial Solutions, Charles River
Title: FDA and EMA Requirements for Relative Potency Bioassays During Standards Qualification
Presenter: Mati Morag, Analytical R&D Director, MediWound Ltd.
Title: Qualification of critical reagents for in-vitro potency bioassays using Curve Parameter Control Strategy
Presenter: Debby Bartfeld, CMC Analytical independent consultant
Title: FDA and EMA requirements for relative potency bioassays during standards qualification
Presenter: Mati Morag, Analytical R&D Director, MediWound Ltd.
Elevate Your Impact – Sponsor This Event
Showcase your organization to key professionals in the pharmaceutical industry by sponsoring this
event. Your support enhances industry knowledge-sharing and professional development while
providing valuable visibility for your brand.